Category: Event
-

G.A.P.P. Webinar: Epic Electronic Medical Record (EMR) – Lessons Learned & Effective Strategies to Implementation
When: January 30, 2025, from 1 – 2:30 pm ET. 3CTN is excited to announce the upcoming G.A.P.P. Webinar: Epic Electronic Medical Record (EMR) – Lessons Learned & Effective Strategies to Implementation. The implementation of hospital-wide EMR systems and resulting process integration have been reported as presenting challenges for Network Cancer Centre trial units. This
-

3CTN Annual Meeting & Workshop 2024
Workshop – Implementing Best Practices for Equity, Diversity and Inclusion (EDI) in Clinical Trials Wednesday, November 13, 2024 Workshop Summary: This workshop will support Network sites’ plans to improve patient access and participation to cancer clinical trials. Current examples of practical, effective approaches undertaken to address EDI priorities will be shared. Facilitated discussions that follow will
-

impACCT Virtual Rounds Fall Session 2024
When: Tuesday, October 22, 2024 12:00 pm -1:00 pm EDT Trial #1: (CCTG) SC.29: A Randomized Phase III Trial Comparing Stereotactic Body Radiotherapy to Conventional Palliative Radiotherapy (SBRT) Versus Conventional Palliative Radiotherapy (CRT) for Participants With Painful Non-Spine Bone Metastases Speaker: Dr. Arjun Sahgal, MD, Chief of Radiation Oncology and the Radiation Treatment Program, Sunnybrook
-

Patient Partner Learning Annex Informational Session
3CTN is excited to announce that we are holding an informational session on June 26, 2024 (1 – 2 pm EDT) for our recently launched Patient Partner Learning Annex tool.
-

impACCT Virtual Rounds Spring Session 2024
When: Thursday, May 23, 2024 12:00 pm -1:00 pm EDT Featured Trial (CHUQ) BicaBCa: A phase II randomized trial of bicalutamide in patients receiving intravesical BCG for non-muscle invasive bladder cancer (NCT05327647) Speaker: Dr. Paul Toren, MD, Associate Professor, Department of Surgery – Faculty of Medicine, Université Laval Speaker: Dr. Joe Pater, MD, Emeritus Professor,
-

impACCT Virtual Rounds Winter Session 2024
When: Thursday, March 7, 2024 12:00 pm -1:15 pm EST Trial #1: OCOG-2022-ROSALIE: Radiation OmisSion in PAtients With CLinically Node Negative Breast Cancer Undergoing Lumpectomy and With a PathologIc Complete REsponse After Neoadjuvant Chemotherapy https://clinicaltrials.gov/study/NCT05866458 Speaker: Dr. Elena Parvez, MD, Assistant Professor, Department of Surgery, McMaster University; Surgical Oncologist at the Juravinski Hospital and Cancer
-

impACCT Virtual Rounds Fall Session 2023
When: Thursday, Sept 28, 2023, 12:00 pm -1:00 pm EDT Trial #1: (UHN) PLAN Prevention of persistent pain with Lidocaine infusions in breast cancer surgery Speaker: James Khan, MD, Assistant Professor and Clinician-Scientist, Department of Anesthesia and Pain Medicine, University of Toronto. Trial #2: (CCTG) CRC.10 / NRG-GI008 A phase II/III study to determine chemotherapy recommendations
-

3CTN’s Annual Stakeholder Meeting (ASM) & Workshops 2023
3CTN is excited to announce that our upcoming Annual Stakeholder Meeting (ASM) & Workshops will be held on October 26-27 2023 in Toronto, please save the date! Registration is now open. Agenda and further details to follow.
-

impACCT Virtual Rounds Spring Session 2023
The Canadian Cancer Clinical Trials Network (3CTN) is pleased to announce the next impACCT Virtual Rounds Spring Session. When: Tuesday, May 16, 2023 12:00 pm -1:00 pm EDT Trial #1: (UoA) ACIT001 / EXC002 A phase 1b/2 multi-center, de-centralized, dose selection study of autologous CD19-directed chimeric antigen receptor (CAR) T-cells in patients with relapsed/refractory aggressive lymphoma
-

G.A.P.P: Overcoming Staffing Challenges at Trials Units Part II
The Canadian Cancer Clinical Trials Network (3CTN) is excited to announce Part II of our G.A.P.P Webinar: Overcoming Staffing Challenges at Trial Units. When: Thursday, February 23, 2023 from 2 – 3 pm EST This webinar will recap discussions from Part I of the webinar and continue the conversation through facilitated discussions to develop actionable
